Literature DB >> 12576936

Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase.

Michael Boulos1, Mark E Astiz, Rajat S Barua, Mohammed Osman.   

Abstract

OBJECTIVE: The purpose of this study was to determine the role of nitric oxide and poly(ADP-ribose) synthase on impaired mitochondrial function in septic shock.
DESIGN: Human umbilical vein endothelial cells were incubated with serum from ten healthy controls, 20 patients with septic shock, and seven critically ill patients who were not septic. The experiment was repeated after pretreatment with 3-aminobenzamide, a poly(ADP-ribose) synthase inhibitor, or N(G)-methyl-L-arginine, a nonspecific nitric oxide synthase inhibitor. MEASUREMENTS: Mitochondrial respiration was measured using a modified MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) assay.
SETTING: Research laboratory. MAIN RESULT: Endothelial cell mitochondrial respiration was significantly depressed by septic serum and averaged 61% +/- 6% of control values (p <.05). Incubation with septic serum as compared with control serum also significantly decreased cellular adenosine triphosphate levels (6.7 +/- 1.2 nM vs. 13.5 +/- 1.9 nM, p<.01). The level of mitochondrial respiration in endothelial cells exposed to septic serum did not correlate with arterial lactate concentration but was correlated with both cardiac output (r(s) =.52, p<.05) and mixed venous oxygen saturation (r(s) =.61, p<.05). Pretreatment with N(G)-methyl-L-arginine significantly increased mitochondrial respiration in endothelial cells treated with septic serum from 63% +/- 6% of normal to 88% +/- 6% (p <.05) of normal values. Similarly, pretreatment with 3-aminobenzamide increased mitochondrial respiration in endothelial cells treated with septic serum from 64% +/- 6% to 100% +/- 4% (p <.01) of normal values. Endothelial cells incubated with serum from nonseptic critically ill patients did not demonstrate a significant decrease in mitochondrial respiration.
CONCLUSION: In vitro mitochondrial respiration was significantly depressed by septic serum. The addition of N(G)-methyl-L-arginine, a nitric oxide synthase inhibitor, and 3-aminobenzamide, a blocker of the poly(ADP-ribose) synthase pathway, significantly attenuated this suppression. These data suggest that nitric oxide and poly(ADP-ribose) synthase activation may play an important role in the inhibition of mitochondrial respiration in septic shock.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576936     DOI: 10.1097/01.CCM.0000050074.82486.B2

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  34 in total

Review 1.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

Review 2.  Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity.

Authors:  Emanuel P Rivers; Lauralyn McIntyre; David C Morro; Kandis K Rivers
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

3.  Organ protective mechanisms common to extremes of physiology: a window through hibernation biology.

Authors:  Quintin J Quinones; Qing Ma; Zhiquan Zhang; Brian M Barnes; Mihai V Podgoreanu
Journal:  Integr Comp Biol       Date:  2014-05-21       Impact factor: 3.326

4.  Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis.

Authors:  Seth W Glickman; Charles B Cairns; Ronny M Otero; Christopher W Woods; Ephraim L Tsalik; Raymond J Langley; Jennifer C van Velkinburgh; Lawrence P Park; Lawrence T Glickman; Vance G Fowler; Stephen F Kingsmore; Emanuel P Rivers
Journal:  Acad Emerg Med       Date:  2010-04       Impact factor: 3.451

Review 5.  MITOCHONDRIAL FUNCTION IN SEPSIS.

Authors:  Nishkantha Arulkumaran; Clifford S Deutschman; Michael R Pinsky; Brian Zuckerbraun; Paul T Schumacker; Hernando Gomez; Alonso Gomez; Patrick Murray; John A Kellum
Journal:  Shock       Date:  2016-03       Impact factor: 3.454

6.  Alterations in Mitochondrial Function in Blood Cells Obtained From Patients With Sepsis Presenting to an Emergency Department.

Authors:  David H Jang; Clinton J Orloski; Shawn Owiredu; Frances S Shofer; John C Greenwood; David M Eckmann
Journal:  Shock       Date:  2019-05       Impact factor: 3.454

7.  The effect of iNOS deletion on hepatic gluconeogenesis in hyperdynamic murine septic shock.

Authors:  Gerd Albuszies; Josef Vogt; Ulrich Wachter; Christoph Thiemermann; Xavier M Leverve; Sandra Weber; Michael Georgieff; Peter Radermacher; Eberhard Barth
Journal:  Intensive Care Med       Date:  2007-04-26       Impact factor: 17.440

Review 8.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

9.  Septic diaphragmatic dysfunction is prevented by Mn(III)porphyrin therapy and inducible nitric oxide synthase inhibition.

Authors:  Nicolás Nin; Adriana Cassina; José Boggia; Evangelina Alfonso; Horacio Botti; Gonzalo Peluffo; Andrés Trostchansky; Carlos Batthyány; Rafael Radi; Homero Rubbo; F Javier Hurtado
Journal:  Intensive Care Med       Date:  2004-09-02       Impact factor: 17.440

Review 10.  Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.

Authors:  Pal Pacher; Csaba Szabo
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.